利奈唑胺治疗“难治性”耐多药结核病 - Suppr

Linezolid in the treatment of 'difficult' multidrug-resistant tuberculosis.

作者信息

Yew W W, Chau C H, Wen K H

出版信息

Int J Tuberc Lung Dis. 2008 Mar;12(3):345-6.

PMID:18284844

Abstract

摘要

相似文献

Linezolid in the treatment of 'difficult' multidrug-resistant tuberculosis.

Int J Tuberc Lung Dis. 2008 Mar;12(3):345-6.

Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis.

Int J Antimicrob Agents. 2009 Jan;33(1):92-3. doi: 10.1016/j.ijantimicag.2008.06.014. Epub 2008 Sep 11.

Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.

J Antimicrob Chemother. 2009 Oct;64(4):879-83; author reply 883-4. doi: 10.1093/jac/dkp265. Epub 2009 Aug 3.

Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.

J Antimicrob Chemother. 2009 Nov;64(5):1119; author reply 1119-20. doi: 10.1093/jac/dkp291. Epub 2009 Aug 8.

Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis--authors' response.

J Antimicrob Chemother. 2009 Nov;64(5):1119-20. doi: 10.1093/jac/dkp344. Epub 2009 Sep 10.

[A hope for multidrug-resistant tuberculosis?].

Rev Med Suisse. 2008 Oct 15;4(175):2233.

Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.

J Antimicrob Chemother. 2009 Aug;64(2):388-91. doi: 10.1093/jac/dkp171. Epub 2009 May 25.

Fatal lactic acidosis after prolonged linezolid exposure for treatment of multidrug-resistant tuberculosis.

Eur J Intern Med. 2009 Oct;20(6):e134-5. doi: 10.1016/j.ejim.2008.12.002. Epub 2009 Jan 23.

Optic neuropathy secondary to Linezolid for multidrug-resistant mycobacterial spinal tuberculosis.

Ocul Immunol Inflamm. 2015 Feb;23(1):90-2. doi: 10.3109/09273948.2013.874447. Epub 2014 Jan 16.

Limited sampling strategies for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis.

Ther Drug Monit. 2010 Feb;32(1):97-101. doi: 10.1097/FTD.0b013e3181cc6d6f.

引用本文的文献

Linezolid for drug-resistant pulmonary tuberculosis.

Cochrane Database Syst Rev. 2019 Mar 20;3(3):CD012836. doi: 10.1002/14651858.CD012836.pub2.

Linezolid manifests a rapid and dramatic therapeutic effect for patients with life-threatening tuberculous meningitis.

Antimicrob Agents Chemother. 2014 Oct;58(10):6297-301. doi: 10.1128/AAC.02784-14. Epub 2014 Aug 4.

Linezolid in the treatment of extensively drug-resistant tuberculosis.

Infection. 2014 Aug;42(4):705-11. doi: 10.1007/s15010-014-0632-2. Epub 2014 Jun 6.

Assessment of linezolid efficacy, safety and tolerability in the treatment of tuberculosis: A retrospective case review.

Can J Infect Dis Med Microbiol. 2013 Fall;24(3):e50-2. doi: 10.1155/2013/535616.

Challenges in the development of drugs for the treatment of tuberculosis.

Braz J Infect Dis. 2013 Jan-Feb;17(1):74-81. doi: 10.1016/j.bjid.2012.10.009. Epub 2013 Jan 1.

Dried blood spot analysis for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis.

Antimicrob Agents Chemother. 2012 Nov;56(11):5758-63. doi: 10.1128/AAC.01054-12. Epub 2012 Aug 27.

Biomarker-assisted dose selection for safety and efficacy in early development of PNU-100480 for tuberculosis.

Antimicrob Agents Chemother. 2011 Feb;55(2):567-74. doi: 10.1128/AAC.01179-10. Epub 2010 Nov 15.

Comparison of the pharmacokinetics of two dosage regimens of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patients.

Clin Pharmacokinet. 2010 Aug;49(8):559-65. doi: 10.2165/11532080-000000000-00000.

Current development and future prospects in chemotherapy of tuberculosis.

Respirology. 2010 Jul;15(5):764-78. doi: 10.1111/j.1440-1843.2010.01775.x. Epub 2010 Jun 4.

Clinical pharmacology and lesion penetrating properties of second- and third-line antituberculous agents used in the management of multidrug-resistant (MDR) and extensively-drug resistant (XDR) tuberculosis.

Curr Clin Pharmacol. 2010 May;5(2):96-114. doi: 10.2174/157488410791110797.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Linezolid in the treatment of 'difficult' multidrug-resistant tuberculosis.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Linezolid in the treatment of 'difficult' multidrug-resistant tuberculosis.

作者信息

出版信息

相似文献

引用本文的文献